| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PRKCD |
| Uniprot No | Q05655 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-676aa |
| 氨基酸序列 | MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED |
| 预测分子量 | 81.6 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于PRKCD(蛋白激酶Cδ型)重组蛋白的3篇代表性文献及其摘要内容概括：
1. **文献名称**：**"Production and characterization of recombinant human PKCδ in Escherichia coli"**
**作者**：Smith A, et al.
**摘要**：该研究描述了通过大肠杆菌表达系统高效生产重组人源PRKCD蛋白的方法，优化了表达和纯化条件，并验证了重组蛋白的激酶活性及在体外磷酸化底物的能力。
2. **文献名称**：**"Structural insights into the autoinhibition of PKCδ by its C-terminal tail"**
**作者**：Lee JH, et al.
**摘要**：本文利用重组PRKCD蛋白的晶体结构分析，揭示了其C端结构域如何通过自抑制机制调控激酶活性，为设计靶向PRKCD的调控分子提供了结构基础。
3. **文献名称**：**"PKCδ recombinant protein induces apoptosis in cancer cells via mitochondrial pathway"**
**作者**：Zhang Y, et al.
**摘要**：研究通过体外实验证明，重组PRKCD蛋白可激活线粒体凋亡通路，促进多种肿瘤细胞凋亡，提示其在癌症治疗中的潜在应用价值。
---
注：以上文献为示例，实际研究中建议通过PubMed或Web of Science检索最新文献。若需具体文章，可补充关键词(如疾病模型或应用场景)进一步筛选。
**Background of PRKCD Recombinant Protein**
PRKCD (Protein Kinase C Delta) is a member of the Protein Kinase C (PKC) family, a group of serine/threonine kinases critical for regulating diverse cellular processes, including proliferation, differentiation, apoptosis, and immune responses. Encoded by the *PRKCD* gene, this enzyme belongs to the novel PKC subfamily (nPKC), which requires diacylglycerol (DAG) but not calcium for activation. PRKCD is ubiquitously expressed and plays a context-dependent role in cell survival and death, often influenced by cellular stressors, signaling pathways, or disease states.
Structurally, PRKCD contains a regulatory domain with tandem C1 domains for DAG binding and a catalytic domain for kinase activity. Its activation involves phosphorylation, membrane translocation, and interaction with cofactors. Dysregulation of PRKCD is linked to cancer, neurodegenerative disorders, and autoimmune diseases. For instance, it acts as a tumor suppressor in some cancers but promotes metastasis in others, highlighting its dual roles.
Recombinant PRKCD protein is produced via genetic engineering, typically using *E. coli*, insect, or mammalian expression systems. This engineered protein retains functional kinase activity and is purified for research applications, such as studying signaling mechanisms, screening kinase inhibitors, or elucidating PRKCD's role in disease models. Tagged versions (e.g., His, GST) facilitate detection and purification.
In drug discovery, recombinant PRKCD aids in identifying therapeutic targets, particularly in cancers or inflammatory conditions where PKCδ pathways are implicated. Its use in *in vitro* assays also helps validate biochemical interactions and post-translational modifications. Overall, PRKCD recombinant protein serves as a vital tool for decoding its complex biological functions and translational potential.
×
